Efficacy of timolol in arresting progression in Keratoconus
Not Applicable
- Conditions
- Health Condition 1: null- Keratoconus
- Registration Number
- CTRI/2017/09/009859
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 120
Inclusion Criteria
Patients between 15 to 30 years of age with a definitive diagnosis of keratoconus as in accordance with guidelines of Collaborative Longitudinal Evaluation of Keratoconus Group
Exclusion Criteria
Patients with associated ocular surface disease
Systemic disorders like bronchial asthma cardiovascular disorders
Pre existing glaucoma or use of antiglaucoma drugs
H/o prior treatment with collagen cross linking
H/o prior corneal hydrops
History of use of contact lens in the last 3 weeks
Pregnancy or lactation during the period of the study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Corneal tomographyTimepoint: Baseline (Day 0), Month 3, and Month 6.
- Secondary Outcome Measures
Name Time Method Best spectacle-corrected Visual Acuity (BSCVA)Timepoint: Baseline (Day 0), Month 3, and Month 6.;Fundus and optic nerve head evaluationTimepoint: Baseline (Day 0), Month 3, and Month 6.;Intraocular pressureTimepoint: Baseline (Day 0), Month 3, and Month 6.;Manifest refractionTimepoint: Baseline (Day 0), Month 3, and Month 6.;Slit lamp biomicroscopyTimepoint: Baseline (Day 0), Month 3, and Month 6.;Uncorrected Visual Acuity (UCVA)Timepoint: Baseline (Day 0), Month 3, and Month 6.